IMUX
Immunic Inc
9.30$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -32.4% | +13.0% | +19.2% | +35.5% | -16.7% | +22.9% | +0.0% | -7.0% | +5.0% | -21.4% | +3.0% | – | |
| – | -2.9% | +67.9% | -31.6% | +1.5% | +3.9% | +2.9% | -7.0% | +90.3% | -63.8% | +241.4% | +51.9% | – | |
| – | +64.6% | -165.7% | – | -46.7% | -95.4% | +2,095.8% | -86.3% | +711.7% | -196.3% | – | -147.6% | – | |
| – | +275.0% | -81.2% | +480.6% | -72.2% | -94.0% | +1,466.7% | -23.4% | +86.1% | -83.6% | -81.8% | +12,350.0% | – | |
| – | +275.0% | -81.2% | +480.6% | -72.2% | -94.0% | +1,466.7% | -23.4% | +86.1% | -83.6% | -81.8% | +12,350.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +114.2% | +12,228.5% | -100.0% | – | – | -100.0% | – | -100.0% | – | +319,632.2% | -99.9% | – | |
| – | – | – | -134.8% | – | – | – | – | -149.2% | – | – | -118.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.